baber/WOPTO huggingface dataset:
Patent AU-2015355337-A1 (AU)
Title: Advance diagnosis of infusion device operating mode viability
Inventor: MONIRABBASI SALMAN
IPC: G16H40/60
Filed: 2015-11-25
Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device to deliver fluid to a user in accordance with an operating mode involves obtaining operational information pertaining to one or more prior instances of the operating mode, obtaining status information pertaining to the infusion device, and determining a diagnosis time based at least in part on the operational information. The diagnosis time is prior to a subsequent instance of the operating mode. At the diagnosis time, the method automatically determines the viability of the subsequent instance of the operating mode based at least in part on the status information and automatically generates a notification indicative of a recommended action for the user based at least in part on the viability.
Patent AU-2015371013-A1 (AU)
Title: Alkali metal bicarbonate particles with increased dissolution time
Inventor: SAVARY DAVID JEAN LUCIEN
IPC: C01D7/22
Filed: 2015-12-22
Abstract: The invention relates to powder compositions comprising alkali metal bicarbonate particles and as additive. The invention also relates to a process for preparing alkali metal bicarbonate particles by spray-drying of an aqueous solution or suspension comprising 1 - 10 % by weight of alkali metal bicarbonate and a resin acid or a fatty acid as additive. The invention further relates to a process for preparing alkali metal bicarbonate particles by co-grinding the alkali metal bicarbonate in the presence of a resin acid as additive. The invention also relates to a process for preparing alkali metal bicarbonate particles by fluidized bed coating of the alkali metal bicarbonate in the presence of a resin acid, fatty acid or a wax as additive.
Patent AU-2015375430-A1 (AU)
Title: Techniques for beam shaping at a millimeter wave base station and fast antenna subarray selection at a wireless device
Inventor: RAGHAVAN VASANTHAN
IPC: H04B7/04
Filed: 2015-12-09
Abstract: Methods, systems, and devices are described for wireless communication at a user equipment (UE). A wireless communications system may improve UE discovery latency by dynamically selecting and switching beam forming codebooks at the millimeter wave base station and the wireless device. Selecting an optimal beam forming codebook may allow the wireless communication system to improve link margins between the base station without compromising resources. In some examples, a wireless device may determine whether the received signals from the millimeter wave base station satisfy established signal to noise (SNR) thresholds, and select an optimal beam codebook to establish communication. Additionally or alternately, the wireless device may further signal the selected beam codebook to the millimeter wave base station and direct the millimeter wave base station to adjust its codebook based on the selection.
Patent AU-2015380995-A1 (AU)
Title: Absorption liquid, method for preparing absorption liquid, and device and method for removing CO2 or H2S or both
Inventor: TANAKA HIROSHI
IPC: C01B32/50
Filed: 2015-10-23
Abstract: An absorption liquid which absorbs the CO
Patent AU-2015413844-A1 (AU)
Title: Real time integrity monitoring of on-shore pipes
Inventor: ETHRIDGE ANDREW DAVID
IPC: F17D5/02
Filed: 2015-11-02
Abstract: A method includes providing a length of pipeline that has a housing defining a central bore extending the length of the pipe and a space formed within the housing and extending the length of the pipe. At least one condition within the space is continuously monitored within the space to detect in real time if a change in the housing occurs.
Patent WO-2016127210-A1 (WO)
Title: Système et procédé de mise en œuvre d'applications de commande à distance à base de capteur et jeux qui sont exécutés sur un dispositif non-capteur
Inventor: WANG SIMON
IPC: A63F13/45
Filed: 2016-02-09
Abstract: La présente invention concerne un procédé de mise en œuvre d'une commande à distance de logiciel, qui permet d'utiliser des applications et des jeux, développés sur la base des capteurs d'un dispositif intelligent, sur un dispositif qui ne présente pas les capteurs correspondants. Le procédé implique une application de client installée sur un dispositif de commande, une application de serveur installée sur le dispositif commandé, et sept processus essentiels, incluant des événements de capture, des positions de carte, des événements d'envoi, des événements d'injection, des effets de capture, des effets d'envoi et des effets de réalisation. Un système mis en œuvre sur la base du procédé comprend une architecture client-serveur, les deux applications, et les composants clés des deux applications ; certains des composants clés mettent en œuvre les fonctions des sept processus.
Patent WO-2016183638-A1 (WO)
Inventor: HOWLETT PATRICK C
IPC: H01M4/13
Filed: 2016-05-20
Abstract: A sodium electrochemical cell that supports a current density at the negative electrode of at least 500 μA/cm 2 , the electrochemical cell comprising (i) a negative electrode and (ii) a sodium-ion ionic liquid electrolyte having a sodium-ion concentration that is no less than 75% of its saturation limit in the electrolyte, wherein the negative electrode has a solid- electrolyte interphase (SEI) layer formed as a result of the electrochemical cell having undergone a polarisation cycle.
Patent WO-2017015712-A1 (WO)
Title: Dispositif de magnéto-encéphalographie
Inventor: JESKE JAN
IPC: H01S3/091
Filed: 2016-07-27
Abstract: La présente invention concerne un dispositif de magnéto-encéphalographie comprenant une pluralité de magnétomètres de seuil laser pour mesurer un champ magnétique. Chaque magnétomètre de seuil laser comprend une cavité optique, un milieu laser qui, conjointement avec la cavité optique, possède un seuil laser ; une pompe à laser ; et un dispositif de commande de radiofréquence (RF) appliqué au milieu laser à une fréquence de résonance particulière ou aux environs d'une fréquence de résonance particulière qui varie en fonction du champ magnétique, de telle sorte qu'en fonction de la valeur du paramètre physique le dispositif de commande de RF induit des transitions entre au moins deux états du milieu laser, chaque état débouchant sur un seuil laser différent dans une intensité d'une sortie laser, l'intensité de la sortie laser fournissant une mesure de l'amplitude du champ magnétique, les magnétomètres de seuil laser étant conçus pour être placés sur la tête d'un sujet à surveiller.
Patent AU-2016200635-A1 (AU)
Title: Antimycotic polymerisable bone cement and a method for the production thereof
Inventor: VOGT SEBASTIAN
IPC: A61L24/02
Filed: 2016-02-02
Abstract: Antimycotic polymerisable bone cement and a method for the production thereof Abstract The invention describes a bone cement with antimycotic efficacy based on organic polymers, such as polymethylmethacrylate. The bone cement comprises an antimycotic agent, in particular amphotericin B, that is released from the polymerised bone cement in the presence of water or aqueous media, such as body fluids. According to one alternative, the antimycotic agent is present in particulate form and is encapsulated, at least in part, by a mixture of at least one 1-methylamino-1-deoxy sugar alcohol and at least one fatty acid. In addition, a method for the production of a mixture comprising an antimycotic agent, such as amphotericin B particles, and 1-methylamino-1-deoxy sugar alcohol and at least one fatty acid is proposed. Preferably, the antimycotic agent is encapsulated, at least partially, by 1 methylamino-1-deoxy sugar alcohol and at least one fatty acid.
Patent AU-2016201373-A1 (AU)
Title: Air conditioner
Inventor: TAKI EIJI
IPC: F25B13/00
Filed: 2016-03-02
Abstract: CPU 210 of an air conditioner 1 checks whether a second frost forming condition is satisfied or not. Specifically, CPU 210 reads out a heat exchanger outlet 5 temperature Teo stored in time series into a memory part 220 to check whether the current heat exchanger outlet temperature Teo is a second threshold temperature or lower or not, whether the drop rate of the heat exchanger outlet temperature calculated using the latest heat exchanger outlet temperature Teo and the second-to-the-latest heat exchanger outlet temperature Teo is a specific drop rate or higher or not, and whether 10 the number of indoor units in operation of indoor units 5a ~ 5c has increased or not during calculation of the drop rate of the heat exchanger outlet temperature. And, when the second frost forming condition is satisfied, CPU 210 switches a four-way valve 22 to set a refrigerant circuit 10 into a cooling cycle to thereby execute a defrosting operation preparation processing and, on completing the defrosting operation 15 preparation processing, resumes a compressor 21 to start a defrosting operation. The thus-structured air conditioner 1 can check with no error whether frost formation has progressed suddenly in an outdoor heat exchanger or not. 35 23 36 24a 24c 24b 44c 2 8a 8b 8c 1 43 27c 22 - - 27b /-- - 31 b-27a-- 33d c - 44b 72a 5a 71a 5a 41-- 26 37 - 44a 5a 61 a "'45 c T'\0a 42 254a 62a 55a 63a 32 34 46 72b 51b 71b61b 53b * 25 5b 9b 54b 62b 55b 63b 72c 51c 71c 53c 5b 61c 54c 62c 55C 63C
Patent AU-2016229119-A1 (AU)
Title: Use of antistatic materials in the airway for thermal aerosol condensation process
Inventor: MYERS DANIEL J
IPC: A61M11/04
Filed: 2016-03-09
Abstract: The disclosure teaches the use of antistatic materials in the airway for thermal aerosol generation devices. The present disclosure teaches the use of antistatic materials for drug delivery in any drug that may be susceptible to charging during aerosol generation.
Patent AU-2016240117-A1 (AU)
Title: Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof
Inventor: YE HONG
IPC: A61K31/7068
Filed: 2016-03-28
Abstract: The present invention relates to a novel compound of 4'-thionucleoside, a preparation method therefor, a pharmaceutical composition comprising the same and an application thereof. Specifically, the present invention relates to a phosphamide derivative of 4'-thionucleoside, a preparation method therefor, a pharmaceutical composition comprising the same, a use thereof in the preparation of a medicine for preventing or treating abnormal cell proliferation diseases (for example, tumors or cancers and related diseases) or virus infectious diseases, and a method of using the same for preventing or treating abnormal cell proliferation diseases (for example, tumors or cancers and related diseases) or virus infectious diseases.
Patent AU-2016246450-A1 (AU)
Title: Chemically modified guide RNAs for CRISPR/Cas-mediated gene regulation
Inventor: PORTEUS MATTHEW H
IPC: C12N15/11
Filed: 2016-04-05
Abstract: Provided herein are methods for inducing CRISPR/Cas-based gene regulation (e.g., genome editing or gene expression) of a target nucleic acid (e.g., target DNA or target RNA) in a cell. The methods include using modified single guide RNAs (sgRNAs) that enhance gene regulation of the target nucleic acid in a primary cell for use in ex vivo therapy or in a cell in a subject for use in
Patent AU-2016256739-A1 (AU)
Title: An illuminated electrical services socket
Inventor: ARAKELIAN RICHARD
IPC: H01R13/629
Filed: 2016-11-09
Abstract: ILLUMINATED VEHICLE SOCKET An electrical socket is described, which is configured to be mounted on a towing vehicle. The electrical socket comprises a socket body, a plug receiver mounted in the socket body and configured to receive a vehicle electrical plug from a towed vehicle, an illuminated closure mounted on the socket body and movable between a closed position in which the plug receiver is closed and an open position in which the plug receiver is accessible to receive the vehicle electrical plug, the illuminated closure comprising a lens and a light source mounted adjacent the lens and configured to direct light through the lens toward the towed vehicle when it is connected to the towing vehicle wherein the light source is also configured to illuminate the plug receiver when the closure is in the open position.
Patent AU-2016261702-A1 (AU)
Title: An additive for a flow battery
Inventor: MAGNES BEN-ZION
IPC: H01M10/36
Filed: 2016-05-09
Abstract: The invention relates to a method of operating a zinc-bromine battery, especially at a high temperature, comprising adding 1- n-butyl-2-methyl-pyridinium bromide to the electrolyte of said battery, and charging or discharging said cell. Also provided is the use of 1-n-butyl-2-methyl-pyridinium bromide as an additive in a zinc-bromine battery operating at a temperature above 30ᵒC, and an aqueous concentrate with high content of 1- n-butyl-2-methyl-pyridinium bromide.
Patent AU-2016270138-A1 (AU)
Title: Systems and methods for managing network traffic with network operator
Inventor: SENARATH NIMAL GAMINI
IPC: H04L47/41
Filed: 2016-06-01
Abstract: A method for managing network slice enabled traffic on a communications network is disclosed. The network slice is instantiated on the communications network for providing connectivity resources to a network operator using the communications network. The method comprises measuring a traffic level indicative of the traffic enabled by the network slice; and adjusting the traffic enabled by the network slice in accordance with the traffic level and a network operator enabled function associated with the network slice
Patent AU-2016272928-A1 (AU)
Title: Improved capsule for the preparation of infused or soluble beverages
Inventor: BISIO LUIGI
IPC: B65D85/804
Filed: 2016-09-28
Abstract: A capsule (1) for the preparation of infused or soluble beverages comprises a cup (2) suitable to contain a substance (11) to be infused or dissolved, provided internally with a base (33) provided with an outer edge (360) and a relief (320) between which is defined a depression (330) for the collection of the infused beverage. The capsule (1) comprises a disc (5) fixed in a peelable manner on the edge (360) so as to separate from it due to the effect of the pressure increase inside the capsule (1). The opening of the capsule (1) occurs as a result of the deformation of the disc (5) due to the pressure exerted by the fluid inside the capsule (1). Advantageously, the base (33), in correspondence of the depression (330), is provided with a plurality of supports (90, 91, 92) provided with a profile decreasing towards the depression (330), suitable to prevent the deformation of the disc (5) from interfering with the outflow of the beverage towards the opening (31).
Patent AU-2016280504-A1 (AU)
Title: Cascaded waveform modulation with an embedded control signal for high-performance mobile fronthaul
Inventor: LIU XIANG
IPC: H04B1/707
Filed: 2016-06-14
Abstract: A method implemented in a communication device, comprising generating, via a processor of the communication device, a first waveform modulation signal based on a first approximation of an input signal, generating, via the processor, a second waveform modulation signal based on a first difference between the input signal S and the first waveform modulation signal, generating, via the processor, a control signal having a sequence of control symbols with a pre-determined modulation format, performing, via the processor, time-domain multiplexing (TDM) on the first waveform modulation signal, the second waveform modulation signal, and the control signal to form a cascaded waveform modulation signal with embedded control signal (CWM-CS), modulating, via a frontend of the communication device, the CWM-CS onto a carrier, and transmitting, via the frontend, the CWM-CS over a communication link to a corresponding communication device in a network.
Patent AU-2016280877-A1 (AU)
Title: Synergistic beverage composition
Inventor: CHIGURUPATI HARSHA
IPC: A23L33/105
Filed: 2016-06-18
Abstract: The invention discloses a synergistic beverage composition for alleviating alcohol-induced oxidative stress, hepatic stress, CNS stress, veisalgia and modulating immunology parameters. The composition comprises saponin glycoside, amino acid derivative and sugar or sugar alcohol as active ingredients and pH adjusting agents and flavouring agents as inactive ingredients. The calculated proportions of amino acid derivatives, Saponin glycoside and sugar or sugar alcohol in the alcohol exhibit synergistic effects, thereby alleviating oxidative stress, hepatic stress, CNS stress, veisalgia and modulating immunology parameters, which could ultimately leads to prevention of alcohol-induced damage or impairment of organs, which could be temporary or permanent.
Patent AU-2016282079-A1 (AU)
Title: Impedance methods and apparatuses using arrays of bipolar electrodes
Inventor: DE LIMON ALFONSO L
IPC: A61B5/053
Filed: 2016-05-20
Abstract: Apparatuses and methods for analyzing a region of a body (including a human body) by electrical impedance, using electrodes driven for bipolar stimulation (bipolar electrodes) and determining a frequency response in electrical properties at a plurality of sub-regions beneath an array of the bipolar electrodes that has been placed on a surface of the body. In particular, the methods and apparatuses described herein may be used to determine tissue wetness based on the change across frequencies based on bio-impedance measured with an array of bipolar electrodes.
Patent AU-2016297916-A1 (AU)
Title: Amphiphilic pyridinium compounds to treat epilepsy and other disorders of the nervous system
Inventor: POLLARD BETTE SILVER
IPC: A61K31/4425
Filed: 2016-07-25
Abstract: A pharmaceutical composition including an amphiphilic pyridinium compound for treating neurological disorders or seizure disorders, in particular epilepsy, and other disorders of the nervous system. The pharmaceutical composition may be used as a primary treatment or as an adjuvant treatment. Administration of the amphiphilic pyridinium compound(s) may occur prior to the manifestation of symptoms characteristic of epilepsy, such that epilepsy is prevented, or alternatively, delayed in its progression. Further, disclosed is a method of treating or preventing infection by Zika Virus, or other arboviruses, in a host that includes administering one or more cardiac glycosides in an amount effective for inhibiting arbovirus infections in a host in need of inhibition of arbovirus infection.
Patent AU-2016298280-A1 (AU)
Title: Anthracene-9, 10-dione dioxime compounds prodrugs and their uses
Inventor: VANKAYALAPATI HARIPRASAD M
IPC: C07C15/28
Filed: 2016-07-28
Abstract: Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures; including, salts thereof that act as anti-cancer and anti-tumor agents, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents.
Patent AU-2016315806-A1 (AU)
Title: Variable rate steam injection, including via solar power for enhanced oil recovery, and associated systems and methods
Inventor: PALMER DANIEL
IPC: E21B43/16
Filed: 2016-08-31
Abstract: Systems and methods for variable rate steam injection, including via solar power for enhanced oil recovery, are disclosed. Several embodiments include using the variable nature of solar-generated steam to improve the efficiency and cost- effectiveness of enhanced oil recovery processes. In particular embodiments, the variable rate injection can provide more uniform steam distribution in an oil-bearing formation, at a lower cost than if the same amount of steam were provided on a continuous basis.
Patent AU-2016335749-A1 (AU)
Title: Exhaust collection bag for cryogenic treatment
Inventor: SYLLIAASEN SCOTT
IPC: A61B18/02
Filed: 2016-10-07
Abstract: An exhaust collection bag for cryogenic treatment is described herein and may generally comprise a first layer and a second layer attached along a periphery and forming an enclosed volume. The periphery defines four radiused corners and an extension member. A tubing connector may be positioned along the first layer and extend through the first layer and may also be located along a centerline of the first layer and in proximity to a bottom edge of the first layer. A drain closure may also be positioned along the first layer and located away from the centerline and in proximity to the bottom edge.
Patent AU-2016336901-A1 (AU)
Title: Bactericidal monoclonal antibody targeting Klebsiella pneumoniae
Inventor: NAGY ESZTER
IPC: C07K16/12
Filed: 2016-10-14
Abstract: A human or humanized monoclonal IgG antibody (mAb) specifically recognizing the D-galactan-ll antigen of
Patent AU-2016375162-A1 (AU)
Title: Glycoprotein V inhibitors for use as coagulants
Inventor: NIESWANDT BERNHARD
IPC: A61K39/395
Filed: 2016-12-23
Abstract: The present invention relates to an inhibitor of platelet glvcoprotein V (GPV) for use as a coagulant, and/or for use in the treatment or prevention of a hemorrhagic condition.
Patent AU-2016381366-A1 (AU)
Title: Methods and compositions for the treatment of seizure-related disorders
Inventor: NGUYEN JACK
IPC: A61K31/192
Filed: 2016-12-30
Abstract: Compositions and methods are provided for administering a pharmaceutical composition to a human patient. Compositions are administered to a human patient orally, once daily, at a therapeutically effective dose. The pharmaceutical compositions comprise a drug selected from the group consisting of brivaracetam, divalproex, lacosamide, levetiracetam, oxcarbazepine, vigabatrin, and pharmaceutically acceptable salts of any of the foregoing, and at least one excipient. At least one of said at least one excipients modifies the release of said drug to provide an extended release form. The pharmaceutical composition have pharmacokinetic properties recited in the claims.
Patent WO-2017197439-A1 (WO)
Inventor: MCKEE BENJAMIN ALEXANDER
IPC: A23L29/30
Filed: 2017-05-18
Abstract: There is provided a prebiotic composition for increasing  Lactobacilli  and/or  Bifidobacteria  levels in the intestine of a mammal wherein the composition consists of a blend of honeys and comprises a total concentration of about 4.0 mg/g to at least 250 mg/g of any combination of trehalose, nigerose, maltulose, isomaltose, panose, turanose, kojibiose and palatinose with at least 0.5 mg/g of nigerose.
Patent WO-2018094444-A1 (WO)
Inventor: DAY WARREN
IPC: F01D1/34
Filed: 2017-11-23
Abstract: This disclosure relates to a fluid flow machine, and a rotor therefore. In one aspect, the rotor contains internal flow channels for a flow medium to travel through, which does work on or extracts work from a fluid. Examples of fluid flow machines include, but are not limited to, gas turbines, turbochargers, compressors, pumps and hydro turbines. In a further aspect, there is provided a reverse flow rotor comprising a rotor body, a shaft on the rotor body to mount the rotor body and shaft in a fluid flow- machine so that the rotor body and shaft can rotate within the fluid flow machine, a plurality of intake and exit openings located on, and radially spaced around, one side of the rotor body, a fluid flow path connecting each intake opening with one exit opening, wherein the fluid flow path is continuously curved between the intake opening and the exit opening.
Patent AU-2017200408-A1 (AU)
Title: Human anti-B7RP1 neutralizing antibodies
Inventor: SIU GERALD
IPC: G01N33/577
Filed: 2017-01-20
Abstract: HUMAN ANTI-B7RP1 NEUTRALIZING ANTIBODIES This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby. The invention 5 also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.